2020. Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation. Journal of Kidney Cancer. 7, 1 (Jun. 2020), 7–11. DOI:https://doi.org/10.15586/jkcvhl.2020.135.